These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35469700)

  • 21. Health Care Access, Utilization, and Cancer Screening Among Low-Income Latina Women.
    Mojica CM; Flores B; Ketchum NS; Liang Y
    Hisp Health Care Int; 2017 Dec; 15(4):160-165. PubMed ID: 29164922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast and cervical cancer screening among women in metropolitan areas of the United States by county-level commuting time to work and use of public transportation, 2004 and 2006.
    Coughlin SS; King J
    BMC Public Health; 2010 Mar; 10():146. PubMed ID: 20302614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy).
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast, cervical, and colorectal cancer screening test use in the US territories of Guam, Puerto Rico, and the US Virgin Islands.
    Gopalani SV; Soman A; Shapiro JA; Miller JW; Ortiz-Ortiz KJ; Castañeda-Avila MA; Buenconsejo-Lum LE; Fredericks LE; Tortolero-Luna G; Saraiya M
    Cancer Epidemiol; 2023 Jun; 84():102371. PubMed ID: 37105018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast and cervical cancer screening disparities associated with disability severity.
    Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
    Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.
    Amboree TL; Montealegre JR; Parker SL; Garg A; Damgacioglu H; Schmeler KM; Chiao EY; Hill EG; Sonawane K; Deshmukh AA; Adsul P
    JAMA Intern Med; 2024 Jun; 184(6):671-679. PubMed ID: 38683574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest.
    Kurani SS; McCoy RG; Lampman MA; Doubeni CA; Finney Rutten LJ; Inselman JW; Giblon RE; Bunkers KS; Stroebel RJ; Rushlow D; Chawla SS; Shah ND
    JAMA Netw Open; 2020 Mar; 3(3):e200618. PubMed ID: 32150271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Coverage and Disparities of Breast and Cervical Cancer Screening in Thai Women: Analysis of National Representative Household Surveys.
    Mukem S; Meng Q; Sriplung H; Tangcharoensathien V
    Asian Pac J Cancer Prev; 2015; 16(18):8541-51. PubMed ID: 26745114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographic disparities in cancer screening and fatalism among a nationally representative sample of US adults.
    Moss JL; Ehrenkranz R; Perez LG; Hair BY; Julian AK
    J Epidemiol Community Health; 2019 Dec; 73(12):1128-1135. PubMed ID: 31615890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.
    Henley SJ; Anderson RN; Thomas CC; Massetti GM; Peaker B; Richardson LC
    MMWR Surveill Summ; 2017 Jul; 66(14):1-13. PubMed ID: 28683054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social disparities in access to breast and cervical cancer screening by women living in Spain.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
    Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
    Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
    [No Abstract]   [Full Text] [Related]  

  • 36. Mediators of county-level racial and economic privilege in cancer screening.
    Munir MM; Woldesenbet S; Alaimo L; Moazzam Z; Lima HA; Endo Y; Beane J; Kim A; Dillhoff M; Cloyd J; Ejaz A; Pawlik TM
    J Surg Oncol; 2023 Jun; 127(7):1212-1222. PubMed ID: 36932957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer Screening Utilization Among Immigrant Women in Miami, Florida.
    Seay JS; Carrasquillo O; Campos NG; McCann S; Amofah A; Pierre L; Kobetz E
    Prog Community Health Partnersh; 2015; 9 Suppl():11-20. PubMed ID: 26213400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
    Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
    J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significantly lower risk of cervical cancer at and after the recommended age to begin and end screening compared to breast and colorectal cancer.
    Whitham HK; Kulasingam SL
    Prev Med; 2015 Jul; 76():135-40. PubMed ID: 25937628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Screening Test Use - United States, 2015.
    White A; Thompson TD; White MC; Sabatino SA; de Moor J; Doria-Rose PV; Geiger AM; Richardson LC
    MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(8):201-206. PubMed ID: 28253225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.